Amgen Reports Fourth Quarter And Full Year 2018 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Amgen (AMGN) Tops Q4 EPS by 14c; Guides FY19 Below the Street
January 29, 2019 4:02 PM ESTAmgen (NASDAQ: AMGN) reported Q4 EPS of $3.42, $0.14 better than the analyst estimate of $3.28. Revenue for the quarter came in at $6.2 billion versus the consensus estimate of $5.87 billion.
GUIDANCE:
Amgen sees FY2019 EPS of $13.10-$14.30, versus the consensus of $14.62. Amgen sees... More
